Summary
This Israeli medical device company has over 20 years of experience in the fields of urology and oncology. The device is based on minimally invasive therapeutic technology. It uses controlled RF (radio frequency) radiation, along with thermos-chemotherapy. The treatment is provided in medical facilities worldwide. The company has an R&D team and provides technical support. They are seeking distributors, as well as to establish commercial agency agreements with healthcare providers.
Description
The company is a well-known manufacturer and supplier of medical devices in Israel, with about 20 years of experience in the local market.
Their clientele covers all types of organizations and stakeholders in the Israeli medical and life science sectors, including the Ministry of Health, hospitals, medical institutions and clinics, as well as universities and research centers.
The staff, which consists of 12 employees, includes professional, skilled employees in the fields of electrical and mechanical engineering, software and QA, product management, customer service, and logistics. In addition, the clinical team includes trained specialists who provide medical support to urology clinics and manages clinical trials around the world.
The company is focused on developing minimally invasive therapeutic technologies, specifically in the field of urology and oncology. The leading technology is a minimally invasive technology that is using non-ionizing microwave radiation and chemotherapy for the treatment of non-muscle invasive bladder cancer. This treatment is based on controlled hyperthermia (through the RF radiation) of the bladder walls, along with installations of the bladder with chemotherapy.
The patient is treated on an outpatient basis in a series of weekly one-hour sessions with no need for anesthesia. The treatment provides reduced recurrence and progression rates and reduced need for operations. The treatment improves patients’ quality of life and is practical and easy to perform by qualified personnel.
The technology is used in medical centrers around the world. It has been proven safe and efficacious in the treatment of non-muscle invasive bladder cancer in numerous routine treatment studies and clinical trials. It is CE certified since 2001 and has been recommended by the European Association of Urology’s Guidelines and by NICE.
The company’s technology can be used by healthcare providers, including medical centers, hospitals, and clinics. In order to globally expand the use of its device, the company is looking for distributors of medical devices, preferably from the fields of urology and oncology. The company would also like to establish commercial agency agreements with healthcare providers interested in the device.